RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:2004

Laryngotracheoesophageal cleft

low confidenceDisorder

Also known as: LC · LTEC · Laryngo-tracheo-esophageal cleft · Laryngo-tracheo-esophageal diastema

Publications

16,903

Trials

3

Interventional, condition-specific

Researchers

1,022

Distinct authors in sample

Gene link

—

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A laryngo-tracheo-esophageal cleft (LC) is a characterized by an abnormal, posterior, sagittal communication between the larynx and the pharynx, possibly extending downward between the trachea and the esophagus.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (6)

Larnygeotracheoesophageal cleft · congenital cleft larynx · laryngeal cleft · laryngo-tracheo-esophageal cleft · laryngo-tracheo-esophageal diastema · tracheal cleft

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    16,903 matched papers (9,159 in last 10 years) Source

  3. Phenotype characterisedPresent

    29 HPO annotations (e.g. Abnormality of the voice; Aspiration; Cyanosis) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPresent

    3 matched on ClinicalTrials.gov (2 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

29

Associated phenotypes · MONDO:0016060

  • Abnormality of the voice
  • Aspiration
  • Cyanosis
  • Laryngeal stridor
  • Laryngomalacia

Showing 5 of 29 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

16,903

16,903 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

16,903 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

9,159 in the last 10 years · low confidence

Phrase hits: 16,903 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,022

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Batra P6 papers · 2026

    Department of Orthodontics and Dentofacial Orthopedics, Manav Rachna Dental College, Manav Rachna International Institute of Research and Studies, Faridabad, IN, India.

    Papers in Europe PMC
  2. 02
    Davies A6 papers · 2026

    The Cleft Collective, Bristol Dental School, The University of Bristol, Bristol, UK.

    Papers in Europe PMC
  3. 03
    Wren Y5 papers · 2026

    The Cleft Collective, Bristol Dental School, The University of Bristol, Bristol, UK.

    Papers in Europe PMC
  4. 04
    Flores RL4 papers · 2026

    Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY.

    Papers in Europe PMC
  5. 05
    Shetye PR4 papers · 2026

    Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY.

    Papers in Europe PMC
  6. 06
    Andari D3 papers · 2026

    Global Smile Foundation, Norwood, MA.

    Papers in Europe PMC
  7. 07
    Bow M3 papers · 2026

    Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia, and.

    Papers in Europe PMC
  8. 08
    Bressmann T3 papers · 2026

    Department of Speech-Language Pathology, University of Toronto, Ontario, Canada.

    Papers in Europe PMC
  9. 09
    Chong DK3 papers · 2026

    From the Department of Plastic and Maxillofacial Surgery, Royal Children's Hospital.

    Papers in Europe PMC
  10. 10
    Das S3 papers · 2026

    Department of Orthodontics, SCB Government Dental College, Cuttack, India.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

3

interventional trials for this specific condition

3 interventional trials matched this specific condition name; 2 currently recruiting in our sample.

Data as of 11 September 2026

3 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 86.7th percentile).

low confidence · 86.7th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

3 interventional trials matched after quoted-phrase search and title/condition post-filter.

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

None of the matched observational studies is currently listed as recruiting.

Open the complete matched search on ClinicalTrials.gov

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Laryngotracheoesophageal cleft — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Laryngotracheoesophageal cleft" OR "Laryngo-tracheo-esophageal cleft" OR "Laryngo-tracheo-esophageal diastema" OR "Larnygeotracheoesophageal cleft" OR "congenital cleft larynx" OR "laryngeal cleft" OR "tracheal cleft"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Laryngotracheoesophageal cleft" OR "Laryngo-tracheo-esophageal cleft" OR "Laryngo-tracheo-esophageal diastema" OR "Larnygeotracheoesophageal cleft" OR "congenital cleft larynx" OR "laryngeal cleft" OR "tracheal cleft"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 3 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: LC; LTEC

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 2 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (16903) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-26T18:43:06.448Z